Found: 1
Select item for more details and to access through your institution.
Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 1, p. 13, doi. 10.1007/s10549-023-06895-2
- By:
- Publication type:
- Article